Multi Cell Technologies, Inc. (OTC:MCET) Heads for a Valley

Multi Cell Technologies, Inc. (OTC:MCET) has been fighting an uphill battle, unable to impress investors with its annual earnings revealed yesterday. The ticker slumped 24% to $0.0038, and while a bargain stock may rise again dramatically, it still can shave off a further percentage before changing directions.

We watched MCET in the past week when the series of up-and-down movements happened, and here is a reminder of the biotechnological company’s financial situation:

• $199,472 cash

• $210,765 current assets

• $1.25 million current liabilities

• $889,555 loss from operating activities

• $49,318 revenues

The company is still ridden by debt and losses, but there are further details in its yearly filings that may serve as further red flags to investors. MCET is capped at $4.7 million currently, and before it started retreating managed to grow 145% in a single day.
The last email for MCET came on February 20th, with no other advertising than the 145% spike. Since then, despite press releases and presentations, the stock has not made a clear trend, turning instead into a risky day trade due to its affordable price. 

The pumper, the Bird Gang Stocks, has not made another pick after MCET. So far, it has made one older attempt to pump a ticker, Dragon Capital Group, Inc. (OTC:DRGV). The stock, priced at $0.004, again turned into an unstable, up-and-down day trade. 

Time will tell if MCET heads upwards again or if another pumper mentions it. MCET was promoted in 2011, with significant spikes in the winter and summer months, quickly reverting to baseline levels. The ticker in the past has been capable of growing three to five times in price, and erasing the gains in just a few trading days. But in any case, it is best to estimate your preferred time horizon and your acceptable losses before going for the extremely cheap penny stock.